Back
Tekla Healthcare Opportunities Fund Vs. VanEck Pharmaceutical ETF Industry Stock Comparison
Sell
25
THQ
Tekla Healthcare Opportunities Fund
Last Price:
20.86
Seasonality Move:
0.53%
Buy
55
PPH
VanEck Pharmaceutical ETF
Last Price:
90.15
Seasonality Move:
5.66%
Sell
25
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $20.59. The Score for THQ is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
VanEck Pharmaceutical ETF (PPH)
is a Buy
Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?
- The current VanEck Pharmaceutical ETF [PPH] share price is $90.01. The Score for PPH is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- PPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $20.59
The current trend is relatively stagnant and THQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
PPH Stock Price Chart
What is VanEck Pharmaceutical ETF's stock price today?
-
The VanEck Pharmaceutical ETF share price today is $90.01
The current trend is relatively stagnant and PPH is experiencing slight buying pressure.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.36 | Sell |
| Relative Strength Index (14 RSI): | 49.82 | Sell |
| Chaikin Money Flow: | 97235 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.9 - 21.26) | Buy |
| Bollinger Bands (100): | (20.68 - 22.04) | Sell |
PPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.06 | Sell |
| Relative Strength Index (14 RSI): | 49.61 | Sell |
| Chaikin Money Flow: | 47982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.02 - 91.72) | Buy |
| Bollinger Bands (100): | (90.71 - 96.79) | Sell |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.94 | Buy |
| 20-day SMA: | 20.4 | Buy |
| 50-day SMA: | 21.31 | Sell |
| 200-day SMA: | 20.63 | Sell |
| 8-day EMA: | 20.18 | Buy |
| 20-day EMA: | 20.43 | Buy |
| 50-day EMA: | 20.94 | Sell |
| 200-day EMA: | 20.57 | Buy |
PPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.2 | Buy |
| 20-day SMA: | 89.26 | Buy |
| 50-day SMA: | 92.22 | Sell |
| 200-day SMA: | 91.64 | Sell |
| 8-day EMA: | 88.86 | Buy |
| 20-day EMA: | 89.5 | Buy |
| 50-day EMA: | 91.45 | Sell |
| 200-day EMA: | 90.71 | Sell |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
VanEck Pharmaceutical ETF Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||